Azenta, Inc. (AZTA)

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
United States Revenue	352.03M	365.00M	365.05M
United States Revenue Growth	-3.55%	-0.01%	3.88%
China Revenue	65.54M	58.35M	58.24M
China Revenue Growth	12.34%	0.18%	11.72%
United Kingdom Revenue	39.89M	35.39M	27.20M
United Kingdom Revenue Growth	12.73%	30.08%	2.04%
Rest of Europe Revenue	110.16M	107.37M	95.15M
Rest of Europe Revenue Growth	2.60%	12.84%	9.14%
Asia Pacific/ Other Revenue	28.70M	27.71M	27.79M
Asia Pacific/ Other Revenue Growth	3.57%	-0.29%	-18.50%
Revenue (Total)	596.33M	593.82M	573.45M
Revenue (Total) Growth	0.42%	3.55%	3.98%

Revenue Breakdown

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
Sample Management Solutions Revenue	326.00M	324.59M	318.90M
Sample Management Solutions Revenue Growth	0.43%	1.79%	5.18%
Multiomics Revenue	270.33M	269.23M	254.55M
Multiomics Revenue Growth	0.41%	5.77%	2.52%
Revenue (Total)	596.33M	593.82M	573.45M
Revenue (Total) Growth	0.42%	3.55%	3.98%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
Multiomics Revenue	270.33M	269.23M	254.55M
Multiomics Revenue Growth	0.41%	5.77%	2.52%
Core Products Revenue	191.87M	197.63M	196.50M
Core Products Revenue Growth	-2.92%	0.57%	2.31%
Sample Repository Solutions Revenue	134.13M	126.96M	122.39M
Sample Repository Solutions Revenue Growth	5.64%	3.73%	10.14%
Revenue (Total)	596.33M	593.82M	573.45M
Revenue (Total) Growth	0.42%	3.55%	3.98%

Adjusted EBIT

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
Sample Management Solutions Adjusted Operating Income	28.06M	27.55M	11.11M
Sample Management Solutions Adjusted Operating Income Growth	1.83%	148.06%	-
Multiomics Adjusted Operating Income	-18.52M	-11.94M	-7.73M
Operating Income (Total)	-172.37M	-26.84M	-51.28M

Key Performance Indicators

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018
Organic Revenue Growth	3.00%	-2.00%

Data Source: Fiscal.ai Last updated: May 8, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error